Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

Todd Neale

July 26, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price

June 22, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

Todd Neale

April 03, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Shelley Wood

January 23, 2018

Advertisement

Complications Following TAVR Are Going Down, US Data Show

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

High Mortality but Durable Results With Valve-in-Valve TAVR

Novel LAA Closure Device Shows Promise in Early Experience

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content